                         SEQUENCE LISTING

<110>  University of Miami
 
<120>  METHOD OF TREATING AN INFLAMMATORY DISORDER

<130>  32286/55166/PC

<150>  PCT/US2021/029218
<151>  2021-04-26

<150>  63/015,896
<151>  2020-04-27

<160>  24    

<170>  PatentIn version 3.5

<210>  1
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada, p-cePhAC, D-Phe-Ada, or PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 5FPhe or Cpa

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Ala or Asn

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Arg or Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me), Amp or 5FPhe

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is Arg or His

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is Lys or Orn

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Abu

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is Arg or His

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Lys or Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har, Har-NH2 or Har-NHCH3

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  Xaa is present or absent and, when present, is Ada-NH2, Ada-NHCH 
       or Ada-NHCH2CH3, or a pharmaceutically acceptable salt thereof

<400>  1

Tyr Arg Asp Ala Ile Xaa Thr Xaa Xaa Xaa Xaa Xaa Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Xaa Xaa Leu Leu Gln Asp Ile Leu Arg Xaa Xaa 
            20                  25                  30  


<210>  2
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 5FPhe or Cpa

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is Ala or Asn

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me) or 5FPhe

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har or Har-NHCH3

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  Xaa is is present or absent and, when present, is Ada-NH2 or 
       Ada-NHCH3, or a pharmaceutically acceptable salt thereof

<400>  2

Tyr Arg Asp Ala Ile Xaa Thr Xaa Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa Xaa 
            20                  25                  30  


<210>  3
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 5FPhe

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  NHCH3

<400>  3

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg 
            20                  25              


<210>  4
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Ada-NH2

<400>  4

Tyr Arg Asp Ala Ile Xaa Thr Asn Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  5
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 5FPhe

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Ada-NH2

<400>  5

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  6
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 5Fphe

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Ada-NH2

<400>  6

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  7
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xa is 5FPhe

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NHCH3

<400>  7

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  8
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NH2

<400>  8

Tyr Arg Asp Ala Ile Xaa Thr Ala Arg Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  9
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NH2

<400>  9

Tyr Arg Asp Ala Ile Xaa Thr Ala Arg Tyr Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  10
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 5FPhe

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NH2

<400>  10

Tyr Arg Asp Ala Ile Xaa Thr Ala Arg Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  11
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Phe-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NH2

<400>  11

Tyr Arg Asp Ala Ile Xaa Thr Ala Arg Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  12
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Amp

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NHCH3

<400>  12

Tyr Arg Asp Ala Ile Xaa Thr Ala Arg Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  13
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NHCH3

<400>  13

Tyr Arg Asp Ala Ile Xaa Thr Asn Arg Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  14
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Aoc-NHCH3

<400>  14

Tyr Arg Asp Ala Ile Xaa Thr Asn Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  15
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Aoc-NHCH3

<400>  15

Tyr Arg Asp Ala Ile Xaa Thr Asn Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  16
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 5FPhe

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NHCH3

<400>  16

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  17
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 5FP4e

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Ada-NHCH3

<400>  17

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa His Xaa Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  18
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 5FPhe

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Ada-NH2

<400>  18

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa His Xaa Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  19
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 5FPhe

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Ada-NH2

<400>  19

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa His Xaa Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  20
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  5FPhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Ada-NH2

<400>  20

Tyr Arg Asp Ala Ile Xaa Thr Asn Arg Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  21
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NH2

<400>  21

Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr Arg Lys Val Leu Gly Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser Arg 
            20                  25                  


<210>  22
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is 5PFPhe

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NH2

<400>  22

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa His Xaa Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  23
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAC-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is 5Fphe

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is Orn

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  NH2

<400>  23

Tyr Arg Asp Ala Ile Xaa Thr Ala Xaa Xaa His Xaa Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala His Xaa Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


<210>  24
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  PhAc-Ada

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Cpa

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Har

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is Tyr(Me)

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Abu

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is Har

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Ada-NH2

<400>  24

Tyr Arg Asp Ala Ile Xaa Thr Asn Xaa Xaa Arg Lys Val Leu Xaa Gln 
1               5                   10                  15      


Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Leu Arg Xaa 
            20                  25                  


